Revenue for AbbVie (ABBV)
According to AbbVie's latest reported financial statements, the company's current revenue (TTM) is $62.82B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
ABBV
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$62.82B
YoY change
+8.6%
5Y CAGR
+6.0%
Peak year (2025)
$61.16B
Cumulative revenue
$579.03B
Revenue history chart for AbbVie (ABBV) from 2009 to 2025
Revenue history table for AbbVie (ABBV) from 2009 to 2025
| Fiscal year | Period ended | Reported | Revenue | YoY | YoY change |
|---|---|---|---|---|---|
| 2025 | $61.16B | +8.6% | +$4.83B | ||
| 2024 | $56.33B | +3.7% | +$2.02B | ||
| 2023 | $54.32B | -6.4% | -$3.74B | ||
| 2022 | $58.05B | +3.3% | +$1.86B | ||
| 2021 | $56.20B | +22.7% | +$10.39B | ||
| 2020 | $45.80B | +37.7% | +$12.54B | ||
| 2019 | $33.27B | +1.6% | +$513.00M | ||
| 2018 | $32.75B | +16.1% | +$4.54B | ||
| 2017 | $28.22B | +10.1% | +$2.58B | ||
| 2016 | $25.64B | +12.2% | +$2.78B | ||
| 2015 | $22.86B | +14.5% | +$2.90B | ||
| 2014 | $19.96B | +6.2% | +$1.17B | ||
| 2013 | $18.79B | +2.2% | +$410.00M | ||
| 2012 | $18.38B | +5.4% | +$936.00M | ||
| 2011 | $17.44B | +11.5% | +$1.81B | ||
| 2010 | $15.64B | +10.0% | +$1.42B | ||
| 2009 | $14.21B | — | — |
Revenue values are taken from AbbVie's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, AbbVie (ABBV) reported revenue of $61.16B – grew 8.6% year-over-year.
AbbVie revenue has grown for 2 consecutive years, with a +6.0% compound annual growth rate over 2020–2025 (5 years).
Across the available history, revenue reached its high of $61.16B in 2025 and its low of $14.21B in 2009.
Among 8 Healthcare peers, AbbVie (ABBV) ranks 6th; the peer median for revenue is $65.05B.
AbbVie Revenue by Year
AbbVie Revenue 2025: $61.16B
AbbVie revenue in 2025 was $61.16B, grew 8.6% from 2024. This figure represents the highest annual value in the available history.
AbbVie Revenue 2024: $56.33B
AbbVie revenue in 2024 was $56.33B, edged up 3.7% from 2023.
AbbVie Revenue 2023: $54.32B
AbbVie revenue in 2023 was $54.32B, declined 6.4% below 2022.
AbbVie Revenue 2022: $58.05B
AbbVie revenue in 2022 was $58.05B, edged up 3.3% from 2021.
AbbVie Revenue 2021: $56.20B
AbbVie revenue in 2021 was $56.20B.
See more financial history for AbbVie (ABBV).
Sector peers — Revenue
Companies in the same sector as AbbVie, ranked by their latest revenue.
| Company | Revenue | Sector |
|---|---|---|
| UnitedHealth Group (UNH) | $447.57B | Healthcare |
| Novo Nordisk (NVO) | $309.06B | Healthcare |
| Johnson & Johnson (JNJ) | $94.19B | Healthcare |
| Eli Lilly (LLY) | $65.18B | Healthcare |
| Merck & Co. (MRK) | $64.93B | Healthcare |
| AstraZeneca (AZN) | $58.74B | Healthcare |
| Thermo Fisher Scientific (TMO) | $44.56B | Healthcare |
| Amgen (AMGN) | $36.74B | Healthcare |
Frequently asked questions
What is AbbVie's revenue?
Latest reported revenue for AbbVie (ABBV) is $62.82B (period ending March 31, 2026).
How has AbbVie revenue changed year-over-year?
AbbVie (ABBV) revenue changed +8.6% year-over-year on the latest annual filing.
What is the long-term growth rate of AbbVie revenue?
AbbVie (ABBV) revenue compound annual growth rate is +6.0% over the most recent 5 years available.
When did AbbVie revenue hit its highest annual value?
AbbVie revenue reached its highest annual value of $61.16B in 2025.
What was AbbVie revenue in 2024?
AbbVie (ABBV) revenue in 2024 was $56.33B.
What was AbbVie revenue in 2025?
AbbVie (ABBV) revenue in 2025 was $61.16B.
ABBV Key Financials
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
ABBV Overview
Company profile, financial tools, and key metrics
ABBV Revenue Counter
Earns $1,992 every second. See per minute, hour, and day.
ABBV Earnings Counter
Earns $115.39 per second net profit. See per minute, hour, and day.
ABBV Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
ABBV What If Invested
What if you had invested $1,000? See historical returns from any date.
ABBV How It Makes Money
Discover visual breakdown of $62.82B in revenue — where it comes from and where it goes.
ABBV Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ABBV Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ABBV Daily Price Character
Steady · 53.6% historical win rate (green days). Streaks & record days.
ABBV Buybacks
0.39% TTM buyback yield. Shareholder yield & SBC comparison.
ABBV Dividend Profile
Yield: 2.97%. Safety: 4/8. See full history.
ABBV Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ABBV Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.
ABBV Dividend Capture
Historical pre-ex touch stats, gap distribution, after-tax calculator, and a backtest simulator (limit-order vs MOC exit).